戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nologic conditions, and various forms of the hypereosinophilic syndrome.
2 atory diseases including allergic asthma and hypereosinophilic syndrome.
3 ive as a corticosteroid-sparing agent in the hypereosinophilic syndrome.
4 with no increase in clinical activity of the hypereosinophilic syndrome.
5  antibody, mepolizumab, in patients with the hypereosinophilic syndrome.
6 ents negative for FIP1L1-PDGFRA who have the hypereosinophilic syndrome.
7 d thrombotic diathesis characteristic of the hypereosinophilic syndrome.
8 eosinophilia-myalgia syndrome and idiopathic hypereosinophilic syndrome.
9 ophilic granulomatosis with polyangiitis and hypereosinophilic syndrome.
10 c gastritis/enteritis, and hypereosinophilia/hypereosinophilic syndrome.
11 n eosinophilic leukemia and the 'idiopathic' hypereosinophilic syndromes.
12  eosinophilic leukemia and in the idiopathic hypereosinophilic syndrome also have been further define
13 symptomatic patients who had PDGFRA-negative hypereosinophilic syndrome and an absolute eosinophil co
14 ively controls eosinophilia in patients with hypereosinophilic syndrome and normal interleukin-5 conc
15 eceptor alpha (PDGFRalpha) as a cause of the hypereosinophilic syndrome and of chronic eosinophilic l
16 DGFRalpha fusion kinase in about half of the hypereosinophilic syndrome cases.
17           The contemporary definition of the hypereosinophilic syndromes encompasses a range of eosin
18               For example, patients with the hypereosinophilic syndrome have received mepolizumab, an
19 reported to be effective in the treatment of hypereosinophilic syndrome (HES) and a rare eosinophilia
20 ity in identifying a subset of patients with hypereosinophilic syndrome (HES) and an underlying myelo
21                                   Idiopathic hypereosinophilic syndrome (HES) and chronic eosinophili
22            None (0%) of 57 patients with the hypereosinophilic syndrome (HES) but 10 (56%) of 19 pati
23                                              Hypereosinophilic syndrome (HES) disease including eosin
24                                   Idiopathic hypereosinophilic syndrome (HES) is a myeloproliferative
25                                   Idiopathic hypereosinophilic syndrome (HES) is a myeloproliferative
26                                              Hypereosinophilic syndrome (HES) is characterized by blo
27                          In 2012, idiopathic hypereosinophilic syndrome (HES) is still the prevalent
28                           Four patients with hypereosinophilic syndrome (HES) refractory to or intole
29                                              Hypereosinophilic syndrome (HES) represents a group of i
30 cytic leukemia (CMML), 101 with MDS, 11 with hypereosinophilic syndrome (HES), 8 with systemic mastoc
31 y is a potential treatment for patients with hypereosinophilic syndrome (HES), although its clinical
32 ene has been identified as a cause of clonal hypereosinophilic syndrome (HES), called F/P-positive ch
33 ne from healthy volunteers and patients with hypereosinophilic syndrome (HES), eosinophilic granuloma
34 (SM) and chronic eosinophilic leukemia (CEL)/hypereosinophilic syndrome (HES).
35 nule proteins were lower than in nonfamilial hypereosinophilic syndrome (HES).
36  therapeutic target for imatinib mesylate in hypereosinophilic syndrome (HES).
37 countered and may lead to the diagnosis of a hypereosinophilic syndrome (HES).
38 s of imatinib response in clinically-defined hypereosinophilic syndrome (HES).
39                                              Hypereosinophilic syndromes (HES) are a heterogenous gro
40                  Although most patients with hypereosinophilic syndromes (HES) present with clinical
41                            In 1968, the term hypereosinophilic syndromes (HES) was coined to refer to
42                                              Hypereosinophilic syndromes (HESs) are a diverse group o
43                                              Hypereosinophilic syndromes (HESs) are a group of rare d
44                                              Hypereosinophilic syndromes (HESs) are a heterogeneous g
45                                              Hypereosinophilic syndromes (HESs) are a rare group of d
46                                              Hypereosinophilic syndromes (HESs) are chronic disorders
47                                              Hypereosinophilic syndromes (HESs) are disorders charact
48 ondary causes of eosinophilia, an idiopathic hypereosinophilic syndrome (I-HES) was diagnosed.
49 esulting in the development of an idiopathic hypereosinophilic syndrome (IHES) with eosinophilic derm
50                                            A hypereosinophilic syndrome in patients after liver trans
51 asthma, allergic and parasitic diseases, and hypereosinophilic syndromes, in addition to more recentl
52 tail the diagnosis and management of various hypereosinophilic syndromes including the clonal eosinop
53          As our understanding of the various hypereosinophilic syndromes increases, and we are able t
54                                   Idiopathic hypereosinophilic syndrome involves a prolonged state of
55                                          The hypereosinophilic syndrome is a group of diseases charac
56                                              Hypereosinophilic syndrome is a group of diseases define
57                                              Hypereosinophilic syndrome is a heterogeneous group of r
58                               The idiopathic hypereosinophilic syndrome is a rare hematologic disorde
59 very of the FIP1L1-PDGFRA fusion gene in the hypereosinophilic syndrome is an example of the power of
60 or patients in whom no underlying disease or hypereosinophilic syndrome is found, the term hypereosin
61                          Lymphocytic variant hypereosinophilic syndrome (LHES) is a rare disorder cha
62                                          The hypereosinophilic syndrome may result from a novel fusio
63 pression was decided in four patients due to hypereosinophilic syndrome, parvovirus infection, aspira
64 ch cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.
65                                Patients with hypereosinophilic syndrome show persistent eosinophilia
66     Ulcerated lesions from patients with the hypereosinophilic syndrome showed ECP and EDN deposition
67                This case may be diagnosed as hypereosinophilic syndrome since eosinophilic pneumonia
68 HES patients compared to patients with other hypereosinophilic syndrome subtypes.
69               Although studied in idiopathic hypereosinophilic syndrome, the therapeutic niche of ant
70  humans and dysregulated in individuals with hypereosinophilic syndrome, this long non-coding RNA may
71 phase 2 trial, patients with PDGFRA-negative hypereosinophilic syndrome who received benralizumab for
72              We treated 11 patients with the hypereosinophilic syndrome with imatinib and identified
73 ssful empiric treatment of patients with the hypereosinophilic syndrome with the selective tyrosine k
74        These may also prove useful for other hypereosinophilic syndromes without PDGFRA or PDGFRB rea